Growing a start-up from a small Danish university spinout to a nasdaq-listed company incorporated in the USA is quite the journey. Join this Talks at the Square to meet CEO Hans Schambye and hear about his personal experience.
Meet Hans Schambye. He will talk about his start-up Galecto which was a small university spin-out company, rooted in deep understanding of the galectin family of proteins and the LOXL2 enzyme. Today Galecto is a clinical-stage company incorporated in the U.S and listed on Nasdaq. This event is free of charge, but seats are limited, so you must sign up here…
Hans Schambye is a seasoned biotech entrepreneur with extensive experience in drug discovery and development. He is also the CEO of Galecto Inc., Chairman of Dansk Biotek and board member at BII. Learn more here…
September 22, 2022, 15.30- 17.00
BioInnovation Institute, Ole Maaløes vej 3, 2200 Copenhagen N.
Anyone with an interest in commercialisation of deep-tech. Especially life science.